carfilzomib (kyprolis) Report issue

Small molecule Orphan Drug FDA Approved FDA Fast Track FDA Accelerated Approval FDA
Back

Drug Pricing Summary

AUS PBS

$163.9682 - $983.8092

VA Big4

$273.7100 - $1627.9500

VA FSS

$407.9000 - $2447.4200

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
carfilzomib 10 mg (INJECTION) $163.9682 AUS PBS generic
  • Kyprolis (1)
  • Amgen Australia Pty Limited
    carfilzomib 10 mg / 5 mL (5 mL INJECTION) $273.7100 VA Big4
  • KYPROLIS (1)
  • Amgen USA, Inc.
    carfilzomib 10 mg / 5 mL (5 mL INJECTION) $407.9000 VA FSS
  • KYPROLIS (1)
  • Amgen USA, Inc.
    carfilzomib 30 mg (INJECTION) $491.9046 AUS PBS generic
  • Kyprolis (1)
  • Amgen Australia Pty Limited
    carfilzomib 30 mg / 15 mL (15 mL INJECTION) $815.1700 VA Big4
  • KYPROLIS (1)
  • Amgen USA, Inc.
    carfilzomib 30 mg / 15 mL (15 mL INJECTION) $1223.7100 VA FSS
  • KYPROLIS (1)
  • Amgen USA, Inc.
    carfilzomib 60 mg (INJECTION) $983.8092 AUS PBS generic
  • Kyprolis (1)
  • Amgen Australia Pty Limited
    carfilzomib 60 mg / 30 mL (30 mL INJECTION) $1627.9500 VA Big4
  • KYPROLIS (1)
  • Amgen USA, Inc.
    carfilzomib 60 mg / 30 mL (30 mL INJECTION) $2447.4200 VA FSS
  • KYPROLIS (1)
  • Amgen USA, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue